Rivaroxaban CAS 366789-02-8 Kuchena > 99.5% (HPLC) Factory API High Quality

Tsanangudzo Pfupi:

Zita reKemikari: Rivaroxaban

CAS: 366789-02-8

Kuchena:> 99.5% (HPLC)

Chitarisiko: Muchena kana Hunenge Hupfu hwachena

API High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name Rivaroxaban
Mashoko anoreva zvakafanana (S)-Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939
Nhamba yeCAS 366789-02-8
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C19H18ClN3O5S
Molecular Weight 435.88
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Upfu Huchena kana Hunenge Huchena
Identification A Iyo infrared absorption yeRivaroxaban inoenderana nereferenzi zviyero
Kuzivikanwa B Iyo nguva yekuchengeta yepamusoro peak yemuenzaniso mhinduro inoenderana neiyo yegadziriro yekukodzera mhinduro, sezvakawanikwa mukuchena kweenantiomeric.
Enantiomeric Purity RVX RC01: ≤0.15%
Kunyorova (KF) ≤0.50%
Sulfated Ash ≤0.10%
Heavy Metals ≤20ppm
Acetic Acid ≤5000ppm
Zvinhu zvinoenderana (HPLC)
RVX RC02 ≤0.15%
RVX RC03 ≤0.15%
RVX RC04 ≤0.15%
RVX RC05 ≤0.15%
RVX RC06 ≤0.15%
RVX RC07 ≤0.15%
RVX RC08 ≤0.15%
Chero Kumwe Kusachena Kwemunhu ≤0.10%
Zvose Zvisina Kuchena <0.50%
Residual Solvents (GC)
Ethanol ≤5000ppm
Toluene ≤890ppm
Triethylamine ≤320ppm
Kuchena / Analysis Method > 99.5% (HPLC) (pane anhydrous basis)
Test Standard Enterprise Standard
Usage API;Antithrombotic Drug;FXa Inhibitor

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

1

FAQ:

Application:

Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) is an oral anticoagulant.Iyo inobata nemuromo yakananga factor Xa inhibitor.Rivaroxaban inoratidzwa nokuda kwe'kurapa kwe-deep vein thrombosis uye pulmonary embolism, nekudzivirira kwekudzoka kwakadzika mutsinga thrombosis uye pulmonary embolism muvakuru'.Nekuda kwekutanga kurapwa kweacute pulmonary embolism, iyo yakakurudzirwa dosage ye rivaroxaban ndeye 15 mg kaviri zuva nezuva kwemazuva ekutanga e21 inoteverwa ne 20 mg kamwe chete zuva nezuva kuti irambe ichirapwa uye kudzivirira kudzokororwa kwevenous thromboembolism.Non-Valvular Atrial Fibrillation (NVAF) kudzivirira sitiroko & systemic embolism.Acute VTE kurapwa & kudzivirira inodzokororwa VTE [yeyakadzika vein thrombosis (DVT) uye pulmonary embolism (PE)].Kudzivirirwa kwevenous thromboembolic zviitiko (VTE) mukusarudzwa kwese hudyu kana kutsiva ibvi kuvhiya (THR, TKR).

Nyora meseji yako pano uye titumire kwatiri